(Q44558846)

4 December 2017

title

In vitro release of nonoxynol-9 from silicone matrix intravaginal rings (English)

1 reference

4 December 2017

Karl Malcolm

1

0 references

author name string

David Woolfson

series ordinal

2

1 reference

4 December 2017

Julie Russell

series ordinal

3

1 reference

4 December 2017

Chris Andrews

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Journal of Controlled Release

4 December 2017

published in

1 reference

4 December 2017

volume

91

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

355-364

1 reference

The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in-vitro

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Barrier contraceptive use and HIV infection among high-risk women in Cameroon.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

A dosing study of nonoxynol-9 and genital irritation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

The effects of three nonoxynol-9 preparations on vaginal flora and epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Electrolytes in vaginal fluid during the menstrual cycle of coitally active and inactive women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Vaginal contraceptive rings

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Design of an intravaginal ring for the controlled delivery of 17 beta-estradiol as its 3-acetate ester

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

High-performance liquid chromatographic determination of 17beta-estradiol and 17beta-estradiol-3-acetate solubilities and diffusion coefficents in silicone elastromeric intravaginal rings

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Drug Delivery by the Intravaginal Route

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Solution-Solubility Dependency of Controlled Release of Drug from Polymer Matrix: Mathematical Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Controlled Drug Release from Polymeric Delivery Devices V: Hydroxy Group Effects on Drug Release Kinetics and Thermodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

A dynamic mechanical method for determining the silicone elastomer solubility of drugs and pharmaceutical excipients in silicone intravaginal drug delivery rings.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Controlled drug release from polymeric delivery devices. II. Differentiation between partition-controlled and matrix-controlled drug release mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Spermicide permeation through biocompatible polymers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Controlled drug release from polymeric delivery devices III: In vitro-in vivo correlation for intravaginal release of ethynodiol diacetate from silicone devices in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Initial clinical studies of intravaginal rings containing norethindrone and norgestrel

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

Peripheral plasma levels of d-norgestrel in women after oral administration of d-norgestrel and when using intravaginal rings impregnated with dl-norgestrel

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900260-8

7 January 2021

10.1016/S0168-3659(03)00260-8

Identifiers

DOI

1 reference

4 December 2017

1 reference